Login / Signup

[Retinal tomography features of thrombotic microangiopathy associated with atypical hemolytic-uremic syndrome].

T V SmirnovaE E KazaryanV M Sheludchenko
Published in: Vestnik oftalmologii (2022)
According to OCT, paracentral acute middle maculopathy is a biomarker of thrombotic retinopathy and the activity of systemic TMA associated with aHUS. Arterial hypertension is an additional aggravating factor in the development of paracentral acute middle maculopathy and transudative macular retinoschisis. Targeted therapy with eculizumab leads to an effective decrease in CRT, which is potentially associated with regression of ischemic edema. The outcome of PLR involves thinning of peripapillary RNFL.
Keyphrases